Monica Garzon
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Journal: Clinical chemistry
Published: May 12, 2020
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
Journal: JAMA oncology
Published: April 10, 2020
Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report.
Journal: Clinical lung cancer
Published: November 19, 2018
Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report.
Journal: Translational lung cancer research
Published: November 09, 2016
KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.
Journal: Translational lung cancer research
Published: November 09, 2016
Liquid Biopsy in Non-Small Cell Lung Cancer.
Journal: Frontiers in medicine
Published: October 31, 2016
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
Journal: Nature communications
Published: October 30, 2016
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Journal: British journal of cancer
Published: August 13, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026